Paper219963
The role of antitumor antibiotics in current oncologic practice.
Davis HL and 3 others. Cancer Chemother Pharmacol, 1978. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The role of antitumor antibiotics in current oncologic practice. Papers, record 219963. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/219963
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibiotics, Antineoplastic | Major topic |
| Neoplasms | Major topic |
| Acute Disease | |
| Adenoma, Islet Cell | |
| Breast Neoplasms | |
| Female | |
| Humans | |
| Hypercalcemia | |
| Leukemia | |
| Lymphoma | |
| Male | |
| Osteosarcoma | |
| Ovarian Neoplasms | |
| Pancreatic Neoplasms | |
| Pregnancy | |
| Soft Tissue Neoplasms | |
| Testicular Neoplasms | |
| Trophoblastic Neoplasms | |
| Uterine Neoplasms |
Source PubMed
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 63314 | Phase II study of mitomycin-C, vincristine, and bleomycin in advanced squamous cell carcinoma of the uterine cervix. | Cancer | 1976 | https://conductscience.org/library/papers/63314 | PubMed |
| 2 | 5587590 | Mechanism of action of chromomycin A3. II. Inhibition of RNA polymerase reaction. | J Biochem | 1967 | https://conductscience.org/library/papers/5587590 | PubMed |
| 3 | 13761819 | Effects of combined drug therapy on metastatic cancer of the testis. | JAMA | 1960 | https://conductscience.org/library/papers/13761819 | PubMed |
| 4 | 819115 | Ewing's sarcoma. | CA Cancer J Clin | 1976 | https://conductscience.org/library/papers/819115 | PubMed |
| 5 | 825200 | Osteogenic sarcoma: advances in treatment. | CA Cancer J Clin | 1976 | https://conductscience.org/library/papers/825200 | PubMed |
| 6 | 1157027 | Advances in chemotherapy for gynecologic cancer. | Cancer | 1975 | https://conductscience.org/library/papers/1157027 | PubMed |
| 7 | 4936148 | New approach to the treatment of hypercalcemia. The effect of short-term treatment with mithramycin. | Clin Pharmacol Ther | 1971 | https://conductscience.org/library/papers/4936148 | PubMed |
| 8 | 5454265 | Hypercalcemia associated with neoplastic disease. | Ann Intern Med | 1970 | https://conductscience.org/library/papers/5454265 | PubMed |
| 9 | 1175165 | Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats. | Cancer Chemother Rep | 1975 | https://conductscience.org/library/papers/1175165 | PubMed |
| 10 | 63574 | Improved chemotherapy in disseminated testicular cancer. | J Urol | 1977 | https://conductscience.org/library/papers/63574 | PubMed |
| 11 | 125624 | The chemotherapy of urologic cancer. | Cancer | 1975 | https://conductscience.org/library/papers/125624 | PubMed |
| 12 | 4353012 | A clinicopathologic analysis of adriamycin cardiotoxicity. | Cancer | 1973 | https://conductscience.org/library/papers/4353012 | PubMed |
| 13 | 947510 | Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study. | Cancer | 1976 | https://conductscience.org/library/papers/947510 | PubMed |
| 14 | 4122362 | A clinical review of bleomycin--a new antineoplastic agent. | Cancer | 1973 | https://conductscience.org/library/papers/4122362 | PubMed |
| 15 | 4371075 | Clinical antitumor activity and toxicity of streptozotocin (NSC-85998). | Cancer | 1974 | https://conductscience.org/library/papers/4371075 | PubMed |
| 16 | 61732 | Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. | Ann Intern Med | 1976 | https://conductscience.org/library/papers/61732 | PubMed |
| 17 | 59858 | Small-cell carcinoma of the lung: attempt to remedy causes of past therapeutic failure. | Lancet | 1976 | https://conductscience.org/library/papers/59858 | PubMed |
| 18 | 5694750 | Mitomycin C therapy in advanced gastrointestinal cancer. | JAMA | 1968 | https://conductscience.org/library/papers/5694750 | PubMed |
| 19 | 1035132 | Phase I alternate-day dose study of chromomycin A3. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/1035132 | PubMed |
| 20 | 4574054 | Daunorubicin (NSC-83142) versus daunorubicin plus prednisone (NSC-10023) versus daunorubicin plus vincristine (NSC-67574) plus prednisone in advanced childhood acute lymphocytic leukemia. | Cancer Chemother Rep | 1972 | https://conductscience.org/library/papers/4574054 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7295513 | Resistance to the cytocidal effects of adriamycin is an early phenotypic change induced during hepatocarcinogenesis. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7295513 | PubMed |
| 6196777 | Alteration and activation of sequence-specific cleavage of DNA by bleomycin in the presence of the antitumor drug cis-diamminedichloroplatinum(II). | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6196777 | PubMed |
| 2374713 | Formation of a DNA monofunctional cis-platinum adduct cross-linking the intercalating drug N-methyl-2,7-diazapyrenium. | Nucleic Acids Res | 1990 | https://conductscience.org/library/papers/2374713 | PubMed |
| 1696245 | Comparative activity of four anthracyclines against heterotransplanted germ cell tumor lines. | Invest New Drugs | 1990 | https://conductscience.org/library/papers/1696245 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/219963
GET https://conductscience.org/api/papers/v1/219963/references?page=2